This media is not supported in your browser
VIEW IN TELEGRAM
Medical experts gathered at the Milken Institute to discuss the need for a major disruption in the field of influenza vaccines in order to role out mRNA technology in the place of traditional egg-based vaccines.
This media is not supported in your browser
VIEW IN TELEGRAM
Rick Bright, former head of BARDA and now with The Rockefeller Foundation, explains how he sabotaged the Emergency Use Authorization of Hydroxychloroquine by limiting its use to a hospital setting.
Air Date: October 13th, 2020
This is an excerpt from the documentary, 'Totally Under Control'
BARDA is the Biomedical Advanced Research and Development Authority
Source: https://www.imdb.com/title/tt13065386/ | https://putlockers.fm/watch/eGLkPVox-totally-under-control.html
Rick Bright now with The Rockefeller Foundation: https://www.rockefellerfoundation.org/profile/dr-rick-bright/
Air Date: October 13th, 2020
This is an excerpt from the documentary, 'Totally Under Control'
BARDA is the Biomedical Advanced Research and Development Authority
Source: https://www.imdb.com/title/tt13065386/ | https://putlockers.fm/watch/eGLkPVox-totally-under-control.html
Rick Bright now with The Rockefeller Foundation: https://www.rockefellerfoundation.org/profile/dr-rick-bright/
already (2) mins into the documentary and there are a lot of things that are inaccurate; unsure if propaganda or just naive. I'll keep watching...
OSINT
Rick Bright, former head of BARDA and now with The Rockefeller Foundation, explains how he sabotaged the Emergency Use Authorization of Hydroxychloroquine by limiting its use to a hospital setting. Air Date: October 13th, 2020 This is an excerpt from the…
for reference, the scientific team @ BARDA that was saying no data exists to support chloroquine having clinical benefits to a coronavirus (SARS-CoV-2, in particular):
https://pubmed.ncbi.nlm.nih.gov/16115318/
this research is well known amongst the scientific community.
coronaviruses are from a family of pathogen called Coronaviridae (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149805 | https://en.wikipedia.org/wiki/Coronaviridae), and SARS-CoV-1 and SARS-CoV-2 are both betacoronaviruses (https://en.wikipedia.org/wiki/Betacoronavirus).
So, if a therapeutic was shown to be effective against a prior known betacoronavirus, there is extremely high probability that said therapeutic/clinical intervention would also be effective by a statistically significant degree with a 'novel' betacoronavirus of the same family of pathogen (Coronaviridae).
As it turns out, Hydroxychloroquine was actually more effective at treating SARS-CoV-2 (particularly in early treatment) than Chloroquine. However, by the time a patient is administered to the hospital/ICU, the 'early treatment' benefits diminish and it becomes far less effective. Hence its continued advocation in being used as early treatment/prophylactic (you can compare early treatment [64% effective] vs late treatment [19% effective] and have a look at a multitude of aggregated studies here: https://hcqmeta.com)
https://pubmed.ncbi.nlm.nih.gov/16115318/
this research is well known amongst the scientific community.
coronaviruses are from a family of pathogen called Coronaviridae (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149805 | https://en.wikipedia.org/wiki/Coronaviridae), and SARS-CoV-1 and SARS-CoV-2 are both betacoronaviruses (https://en.wikipedia.org/wiki/Betacoronavirus).
So, if a therapeutic was shown to be effective against a prior known betacoronavirus, there is extremely high probability that said therapeutic/clinical intervention would also be effective by a statistically significant degree with a 'novel' betacoronavirus of the same family of pathogen (Coronaviridae).
As it turns out, Hydroxychloroquine was actually more effective at treating SARS-CoV-2 (particularly in early treatment) than Chloroquine. However, by the time a patient is administered to the hospital/ICU, the 'early treatment' benefits diminish and it becomes far less effective. Hence its continued advocation in being used as early treatment/prophylactic (you can compare early treatment [64% effective] vs late treatment [19% effective] and have a look at a multitude of aggregated studies here: https://hcqmeta.com)
PubMed
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread - PubMed
Chloroquine is effective in preventing the spread of SARS CoV in cell culture. Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection. In addition, the indirect immunofluorescence…
https://www.westernjournal.com/workers-maintain-supply-chains-issue-bone-chilling-warning-every-american-needs-hear/ #supplychain
The Western Journal
Workers Who Maintain Supply Chains Issue Bone-Chilling Warning Every American Needs to Hear
The people responsible for transporting global freight are warning of a total supply chain collapse thanks to coronavirus restrictions.
Media is too big
VIEW IN TELEGRAM
Propaganda and Manipulation - How American Mass Media Engineers and Distorts Our Perceptions by Prof. Jerry Kroth
Media is too big
VIEW IN TELEGRAM
The Media Matrix - How Propaganda and Mass Media Are Altering Our Contact with Reality by Prof. Jerry Kroth
What's really funny, is this guy is buying up the official narrative completely. It's quite ironic if you watch some of his recent videos on the 'RONA. The comments are funny, as most people are calling him out.
Nonetheless, this is good info. Should also read 'Propaganda' by Edward Bernays, and 'Manufacturing Consent' by Noam Chomsky. You can understand a little more how people are so gaslit, but it's still hard to fathom these people's subservient behavior.
Nonetheless, this is good info. Should also read 'Propaganda' by Edward Bernays, and 'Manufacturing Consent' by Noam Chomsky. You can understand a little more how people are so gaslit, but it's still hard to fathom these people's subservient behavior.
SEC filing for Moderna's mRNA gene therapy 'vaccine'
https://www.sec.gov/Archives/edgar/data/1682852/000168285220000017/mrna-20200630.htm
https://www.sec.gov/Archives/edgar/data/1682852/000168285220000017/mrna-20200630.htm
https://www.sec.gov/Archives/edgar/data/1776985/000119312519241112/d635330df1.htm
BioNTech (Pfizer) SEC filing
"Currently, mRNA is considered a gene therapy product by the FDA.”
BioNTech (Pfizer) SEC filing
"Currently, mRNA is considered a gene therapy product by the FDA.”